- ￥1280 - 1980
- YLKBIO
- YLK-KT2039D
- 国产
- 2025年07月16日
- WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 兔
- /
6 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
优利科（上海）生命科学有限公司
- 库存：
63
- 靶点：
/
- 级别：
科研
- 目录编号：
/
- 克隆性：
多克隆
- 抗原来源：
详见说明书
- 保质期：
1年
- 抗体英文名：
Anti-Phospho-IRAK1 (Thr387)
- 抗体名：
Phospho-IRAK1 (Thr387)抗体
- 标记物：
详询
- 宿主：
兔
- 适应物种：
/
- 免疫原：
KLH conjugated synthesised phosphopeptide derived from human IRAK1 around the phosphorylation site of Thr387 [RG(p-T)LA]
- 亚型：
IgG
- 形态：
Lyophilized or Liquid
- 应用范围：
WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 保存条件：
-20℃
- 浓度：
1mg/ml
- 规格：
详询
| 英文名称 Anti-Phospho-IRAK1 (Thr387) |
| 中文名称 磷酸化白介素-1受体相关激酶1抗体 |
| 别 名 IRAK1 (Phospho-Thr387); IRAK1 (Phospho-T387); IRAK1 (p-Thr387); Il1rak; Il1rak; Interleukin 1 receptor associated kinase 1; Interleukin 1 receptor associated kinase 1; Interleukin 1 receptor associated kinase 2; Interleukin-1 receptor-associated kinase 1; IRAK; IRAK-1; IRAK1; IRAK1; IRAK1_HUMAN; IRAK2; IRAK2; mPLK; mPLK; Pelle; Pelle; Pelle homolog; Pelle-like protein kinase; Plpk. |
| 浓 度 1mg/1ml |
| 规 格 0.1ml/100μg |
| 抗体来源 Rabbit |
| 克隆类型 polyclonal |
| 交叉反应 Human, Mouse, Rat, Dog, Pig, Cow, Rabbit |
产品类型 一抗 磷酸化抗体  |
| 研究领域 肿瘤 免疫学 信号转导 细胞凋亡 |
| 蛋白分子量 predicted molecular weight: 78kDa |
| 性 状 Lyophilized or Liquid |
| 免 疫 原 KLH conjugated synthesised phosphopeptide derived from human IRAK1 around the phosphorylation site of Thr387 [RG(p-T)LA] |
| 亚 型 IgG |
| 纯化方法 affinity purified by Protein A |
| 储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide |
| 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| （石蜡切片需做抗原修复） |
| not yet tested in other applications. |
| optimal dilutions/concentrations should be determined by the end user. |
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.  |
| Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 IRAK or Interleukin-1 Receptor-associated Kinase 1, is one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. This protein is partially responsible for IL1-induced upregulation of the ubiquitous transcription factor NF-kappa B. |
| Function : Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3 |
| Subunit : Homodimer. Interacts with TOLLIP; this interaction occurs in the cytosol prior to receptor activation. Interacts with MYD88; this interaction recruits IRAK1 to the stimulated receptor complex. Interacts with IL1RL1. Interacts with IRAK1BP1. Associates with TRAF6, PELI1 and IRAK4; this complex recruits MAP3K7/TAK1, TAB1 and TAB2 to mediate NF-kappa-B activation. Interacts (when polyubiquitinated) with IKBKG/NEMO. |
| Subcellular Location : Cytoplasm. Nucleus. Note=Translocates to the nucleus when sumoylated. |
| Tissue Specificity : Isoform 1 and isoform 2 are ubiquitously expressed in all tissues examined, with isoform 1 being more strongly expressed than isoform 2. |
| Post-translational modifications : Following recruitment on the activated receptor complex, phosphorylated on Thr-209, probably by IRAK4, resulting in a conformational change of the kinase domain, allowing further phosphorylations to take place. Thr-387 phosphorylation in the activation loop is required to achieve full enzymatic activity. |
| Polyubiquitinated after cell stimulation with IL-1-beta by PELI1, PELI2 and PELI3. Polyubiquitination occurs with polyubiquitin chains linked through 'Lys-63'. Ubiquitination promotes interaction with NEMO/IKBKG. Also sumoylated; leading to nuclear translocation. |
| Similarity : Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. Pelle subfamily. |
| Contains 1 death domain. |
| Contains 1 protein kinase domain. |
| Database links : UniProtKB/Swiss-Prot: P51617.2 |
IRAK or Interleukin-1 Receptor-associated Kinase 1, is one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. This protein is partially responsible for IL1-induced upregulation of the ubiquitous transcription factor NF-kappa B. |
| AM Adrenomedullin 肾上腺髓质素（抗原） |
| TIMP-2(Tissue Inhibitor of Metalloproteinase-2) 金属蛋白酶组织抑制因子-2(抗原) |
| TIMP-3(Tissue Inhibitor of Metalloproteinase-3) 金属蛋白酶组织抑制因子(抗原) |
| ADM R, Adrenomedullin receptor 肾上腺髓质素受体（抗原） |
| Amylin1-37/FITC 异硫 酸荧光素(FITC)标记糖尿病相关肽1-37 |
| VTG(vitellogenin) 青鳉鱼卵黄蛋白 |
| Apaf-1 （Apoptosis protease activating factor-1）(CT) 凋亡蛋白活性因子-1（抗原） |
| Apaf-1 （Apoptosis protease activating factor-1）(NT) 凋亡蛋白活性因子-1（抗原） |
| AR （Androgen Receptor) 雄激素受体（抗原） |
| AT （Angiotenogen） 血管紧张素原（抗原） |
| Apo-E （Apolipoprotein E） 载脂蛋白E（抗原） |
| IKI3 family protein |
| ILK-1 (Integrin-linked protein kinase 1) 整合素连接激酶-1 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
3 篇 Nature 连发，解决世纪难题，周期蛋白的毁灭调控蕴含癌症患者的新生
细胞周期是细胞生命活动的基本过程，受到细胞内外信号交互作用的精密调控。D 型细胞周期蛋白 (cyclin D1, D2 和 D3) 与细胞周期蛋白依赖性激酶（cyclin-dependent kinases，CDKs）是整个细胞周期调控机制中的核心分子，驱动细胞增殖。细胞周期失调是人类癌症的一个共同特征，其中 cyclin D-CDK4/6 复合物的水平和活性与不受约束的细胞增殖密切相关。自从 20 世纪 90 年代发现 cyclin D 以来，人们就对其进行了深入研究，但是关于 cyclin
的作用。例如，组蛋白 H3N 端的磷酸化可能促进染色质在有丝分裂期间的凝集。在哺乳动物中，aurora B 是有丝分裂时 H3S10 磷酸化的激酶，但是在存在 aurora B 对 H3S10 的磷酸化是不够的。牛痘苗相关激酶 1 是哺乳动物 NHK1 的同系物，它能在体内和体外直接使组蛋白 H3T3 和 H3S10 磷酸化，而失去 VPK1 的活性，组蛋白 H3 的磷酸化也将减少。 组蛋白 H1 被细胞周期蛋白依赖的磷酸化是其翻译后主要的修饰作用。组蛋白 H1 的磷酸化能够影响 DNA 二级
网络 第二节 蛋白酪氨酸激酶 蛋白酷氨酸激酶（protein tyrosine kinase,PTK）是一类催化ATP上γ-磷酸转移到蛋白酪氨酸残基上的激酶，能催化多种底物蛋白质酪氨酸残基磷酸化，在细胞生长、增殖、分化中具有重要作用。迄今发现的蛋白酪氨酸激酶中多数是属于致癌RNA病毒的癌基因产物，也可由脊椎动物的原癌基因产。根据PTK是否存在于细胞膜受体
磷酸化白介素-1受体相关激酶1抗体
￥1280 - 1980
